Data Foundry

Drug recalls 2019

Losartan Potassium and Hydrochlorothiazide Tablets — Class II drug recall D-1267-2019

Ongoing recall by Torrent Pharma Inc., reported 2019-05-08, distributed nationwide. CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished

Recall numberD-1267-2019
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmTorrent Pharma Inc., Basking Ridge, NJ, United States
Recall initiated2019-04-18
Classified2019-05-01
Reported by FDA2019-05-08
DistributedNationwide (US)
Quantity331,764 bottles
Reason classescgmp, specification failure
NDC13668-0116-10, 13668-0116-30, 13668-0116-90
Lot numbersBEF7D003, BEF7D005, BEF7D026, BEF7D027, BEF7D028, BEF7D029, BEF7D030, BEF7D045, BEF7D046, BEF7D047, BEF7D048, BEF7E001, BEF7E002, BEF7E003, BEF7E004, BEF7E005, BP02C050, BP02C051, BP02C052, BP02D005, BP02D006, BP02D007, BP02D012
Expiration dates2019-10-31, 2019-12-31, 2020-01-31, 2020-03-31, 2020-08-31, 2020-11-30, 2020-12-31, 2021-01-31

Product

Losartan Potassium and Hydrochlorothiazide Tablets, USP, 50mg/12.5mg, a) 30-count (NDC: 13668-116-30), b) 90-count (NDC: 13668-116-90), c) 1000-count (NDC: 13668-116-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India

Reason for recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1267-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.